{"entity":{"id":"nct06939283","kind":"trial","name":"A Phase 1b/2 Multisite Dose-finding and Expansion Study of WTX-330 in Adult Patients With Selected Advanced or Metastatic Solid Tumors or Lymphoma","aka":[],"tldr":"A phase 1/2 trial of WTX-330 in non-Hodgkin lymphoma, run by Werewolf Therapeutics, Inc., active and no longer recruiting.","summary":"A Phase 1b/2 Multisite Dose-finding and Expansion Study of WTX-330 in Adult Patients With Selected Advanced or Metastatic Solid Tumors or Lymphoma is a phase 1/2 interventional study registered as NCT06939283 by Werewolf Therapeutics, Inc., with 100 participants enrolled, started 2025-05-07 and due to reach its primary completion in 2028-08. Interventions recorded: WTX-330.","status":"active","asOf":"2026-09-16","links":[{"label":"ClinicalTrials.gov NCT06939283","url":"https://clinicaltrials.gov/study/NCT06939283"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["non-hodgkin-lymphoma"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":["werewolf-therapeutics"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"nct":"NCT06939283","phase":"1/2","setting":"A Phase 1b/2 Multisite Dose- and Regimen-finding and Expansion Study of WTX-330 in Adult Patients With Selected Advanced or Metastatic Solid Tumors or Non-Hodgkin Lymphoma (NHL)","sponsor":"Werewolf Therapeutics, Inc.","enrolled":100,"outcomes":[]},"route":"/trials/nct06939283/","neighbours":{"cancer":[{"id":"non-hodgkin-lymphoma","kind":"cancer","name":"Non-Hodgkin lymphoma (all types)","route":"/cancers/non-hodgkin-lymphoma/"}],"company":[{"id":"werewolf-therapeutics","kind":"company","name":"Werewolf Therapeutics","route":"/companies/werewolf-therapeutics/"}]}}